DRG research indicates that about 200 launches are expected during 2017-2019, of which approximately 14% are forecast to become blockbusters. The new launches in this period will garner sales of about $90 billion in the major markets by 2025 of which about 80% will be generated by blockbuster drugs.

The below infographic utilizes research from DRG’s Disease Landscape & Forecast, and Company & Drug Insights – contact Questions@TeamDRG.com to learn how to gain access the full research (or to see if your company already has access).

Medtech Account Segmentation and Targeting

View Now